top headlines
Pheno Therapeutics has secured two patents protecting its GPR17 antagonist [...]
Grifols has presented real-world data on therapeutic plasma exchange with [...]
Movers & Shakers
sponsored content
Other news
ProMIS Neurosciences has licensed a brain-selective delivery technology from Ossianix, [...]
Dicot Pharma has started a Phase 2b clinical trial of [...]
Skylark Bio has received unanimous independent safety board support to [...]
Fonseca Biosciences has reported positive pooled Phase 3 results for [...]
Almirall has received a positive CHMP opinion recommending an expanded [...]
ProMIS Neurosciences has licensed Ossianix’s TXP1 technology to improve antibody [...]









